Profile data is unavailable for this security.
About the company
Microba Life Sciences Limited is an Australia-based precision microbiome company. The Company is engaged in the discovery and development of therapeutics for chronic diseases and delivering gut microbiome testing services globally to researchers, clinicians, and consumers. It offers various platforms, such as Analysis, Discovery, and Therapeutic. Its Analysis platform is an end-to-end solution for microbiome analysis. Using advanced metagenomic sequencing technology and proprietary bioinformatic tools, it provides precise and comprehensive measurement of the human gut microbiome. Its Discovery Platform is a global databank for microbiome discovery and develops new health solutions from the gut microbiome. Its Therapeutic platform is a repeatable platform for microbial therapeutic leads. Its Diagnostic testing products are MetaXplore and MetaPanel. MetaXplore offers a comprehensive gastrointestinal testing solution. MetaPanel is an advanced gastrointestinal pathogen detection panel.
- Revenue in AUD (TTM)15.67m
- Net income in AUD-14.94m
- Incorporated2017
- Employees--
- LocationMicroba Life Sciences Ltd324 Queen Street, Level 10BRISBANE 4000AustraliaAUS
- Phone+61 73222-8444
- Websitehttps://www.microba.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genetic Technologies Ltd | 3.71m | -8.65m | 52.08m | 58.00 | -- | -- | -- | 14.05 | -0.0571 | -0.0642 | 0.0247 | -0.0149 | 0.7258 | 10.10 | 5.88 | 63,898.28 | -169.41 | -56.05 | -601.58 | -66.86 | 45.93 | 51.10 | -233.43 | -190.20 | 0.446 | -208.39 | -- | -- | -11.76 | 213.18 | -2.27 | -- | -8.10 | -- |
| Microba Life Sciences Ltd | 15.67m | -14.94m | 52.98m | -- | -- | 1.38 | -- | 3.38 | -0.0333 | -0.0333 | 0.0349 | 0.0631 | 0.2953 | 3.94 | 12.62 | -- | -28.16 | -34.53 | -35.75 | -42.28 | 47.49 | 49.17 | -95.34 | -159.98 | 1.68 | -- | 0.0904 | -- | 29.60 | 40.04 | 25.07 | -- | 27.63 | -- |
| Cryosite Ltd | 14.12m | 1.88m | 53.69m | 25.00 | 29.13 | 22.47 | 19.49 | 3.80 | 0.0378 | 0.0378 | 0.2834 | 0.049 | 0.7206 | 102.47 | 7.87 | 564,640.00 | 9.62 | 6.66 | 12.29 | 8.09 | 62.98 | 60.87 | 13.35 | 11.83 | 1.95 | -- | 0.4869 | -- | 11.93 | 9.38 | 2.39 | 4.94 | -8.42 | -- |
| Cleo Diagnostics Ltd | 1.18m | -4.00m | 82.12m | -- | -- | 13.21 | -- | 69.31 | -0.0314 | -0.0314 | 0.0092 | 0.0454 | 0.1409 | -- | 18.51 | -- | -47.57 | -- | -52.53 | -- | -- | -- | -337.54 | -- | -- | -- | 0.00 | -- | 97.41 | -- | -6.38 | -- | -- | -- |
| Apiam Animal Health Ltd | 206.92m | 832.00k | 160.98m | -- | 230.77 | 1.32 | 11.82 | 0.778 | 0.0038 | 0.0038 | 1.11 | 0.6613 | 0.809 | 4.57 | 15.75 | -- | 0.3378 | 1.65 | 0.3896 | 1.93 | 66.22 | 63.46 | 0.4175 | 1.97 | 0.5026 | 2.33 | 0.4586 | 71.37 | 1.11 | 11.83 | -83.13 | -27.29 | 27.96 | 0.3129 |
| Eureka Group Holdings Ltd | 45.79m | 20.06m | 211.16m | 42.00 | 9.78 | 0.8739 | 10.28 | 4.61 | 0.0506 | 0.0506 | 0.1189 | 0.5664 | 0.1506 | -- | 206.26 | -- | 6.60 | 6.12 | 6.75 | 6.29 | 54.76 | 52.75 | 43.81 | 37.02 | -- | -- | 0.1908 | 30.22 | 11.30 | 13.04 | 51.90 | 19.90 | 21.25 | 6.71 |
| Holder | Shares | % Held |
|---|---|---|
| Perennial Value Management Ltd.as of 01 Aug 2024 | 64.14m | 10.53% |
| Mercer Investments (Australia) Ltd.as of 28 Oct 2025 | 32.31m | 5.31% |
| Thorney Investment Group Australia Pty Ltd.as of 01 Aug 2024 | 29.96m | 4.92% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 15.12m | 2.48% |
